Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO™; results surpass current standards of care RARITAN, N.J., Feb. 19, 2026 /PRNewswire/ -- Johnson &
Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports
02:34pm, Thursday, 19'th Feb 2026
Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with big buyout firms already circling, Bloomberg News reported on Thursday, citing peopl
Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility
02:11pm, Thursday, 19'th Feb 2026
Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over 500 manufacturing jobs plus 4,000 construction jobs.
2 High-Yield CEFs To Enhance Your Retirement Income
09:15am, Thursday, 19'th Feb 2026
2 High-Yield CEFs To Enhance Your Retirement Income
5 Dividend-Paying Giants Have Been on Goldman Sachs Conviction List the Longest
08:18am, Thursday, 19'th Feb 2026
Goldman Sachs is the acknowledged leader in the investment landscape on Wall Street and worldwide.
First Look: Walmart beat, Meta trial, FDA eyes Moderna
07:39am, Thursday, 19'th Feb 2026
Stock News Zuckerberg testifies in youth harm case: Meta Platforms (META) CEO Mark Zuckerberg defended Instagram's design and policies in a Los Angeles trial ov
Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory
10:44am, Wednesday, 18'th Feb 2026
The facility is part of the company's plans to invest $55 billion in U.S. manufacturing, research and development and technology through early 2029.
J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push
10:17am, Wednesday, 18'th Feb 2026
Johnson & Johnson said on Wednesday it will invest more than $1 billion to build a new cell therapy facility in Pennsylvania, part of its larger plans announced last year to scale up U.S. manufacturin
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare's leading, most comprehensive innovation powerhouse, today announced a more than $1 billion investme
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Wednesday, 18'th Feb 2026
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy?
09:15am, Wednesday, 18'th Feb 2026
Verizon (NYSE: VZ) and Johnson & Johnson (NYSE: JNJ) both rewarded shareholders with dividend increases this quarter, but their paths to sustaining those payouts look very different.
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO™ beyond lung cancer RARITAN, N.J., Feb. 18
Right Now Retirees Should Forget Dividend Stocks And Flip to This Income Strategy Instead
06:14am, Wednesday, 18'th Feb 2026
Traditional dividend stocks have long been the go-to for income investors. However, covered call ETFs have emerged as a compelling alternative, generating income through options premiums rather than w
Trellus Health shares double in early deals on J&J extension
04:02am, Wednesday, 18'th Feb 2026
Trellus Health PLC (AIM:TRLS) shares more than doubled in Wednesday's early trade after it announced it had secured a six-month contract extension with Johnson & Johnson Health Care Systems, keeping
This State Has More Millionaires Per Capita Than Any Other
09:21pm, Tuesday, 17'th Feb 2026
There are many ways to describe America. Some might call it a veritable patchwork of diverse cultures and social strata. That's a fancy way of saying that prosperity is concentrated in some U.S. state
